Suppr超能文献

载脂蛋白E ε4基因型对复发缓解型多发性硬化症脑组织完整性的影响。

Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis.

作者信息

De Stefano Nicola, Bartolozzi Maria Letizia, Nacmias Benedetta, Zipoli Valentina, Mortilla Marzia, Guidi Leonello, Siracusa Gianfranco, Sorbi Sandro, Federico Antonio, Amato Maria Pia

机构信息

Department of Neurological and Behavioral Sciences, University of Siena, Siena, Italy.

出版信息

Arch Neurol. 2004 Apr;61(4):536-40. doi: 10.1001/archneur.61.4.536.

Abstract

BACKGROUND

Recent clinical and imaging studies have raised the hypothesis that patients with multiple sclerosis (MS) and the apolipoprotein E (ApoE) epsilon4 allele may have a more severe disease course than those without the ApoE epsilon4 allele. This seems to be related to more extensive tissue destruction and less efficient neuronal maintenance and repair in ApoE epsilon4 carriers.

OBJECTIVE

To evaluate the influence of different ApoE genotypes on brain tissue integrity in patients with relapsing-remitting MS (RRMS).

DESIGN

We determined the ApoE genotype in 76 RRMS patients. Conventional T1-, T2-, and proton density-weighted magnetic resonance (MR) images were obtained for each patient and in a group of demographically matched healthy control subjects. On conventional T1-weighted MR images, an automated analysis tool was used to obtain total brain volumes normalized for head size (NBVs). Total brain lesion load was estimated on proton density- and T2-weighted MR images.

RESULTS

From the whole group of RRMS patients, we identified 18 with and 58 without the epsilon4 allele. Both patient groups were not significantly different in age, age of disease onset, clinical disability, and disease duration. Carriers of the epsilon4 allele showed significantly (P =.01) lower NBVs than controls and non-epsilon4 allele carriers. When a similar analysis was performed on only those patients with both very short disease duration and absence of clinical disability, NBV values were still significantly lower in RRMS patients with the epsilon4 allele than in those without it (P =.02) and in controls (P =.007). In contrast, RRMS patients with different ApoE genotypes did not show significant differences in values of total brain T2-weighted lesion volumes.

CONCLUSIONS

The presence of significant NBV decreases only in the group of RRMS patients with the ApoE epsilon4 genotype provides new evidence that links ApoE epsilon4-related impaired mechanisms of cell repair and severe tissue destruction in MS. Results of the present study suggest that this negative influence of the ApoE epsilon4 genotype might be active from the earliest disease stages.

摘要

背景

近期的临床和影像学研究提出了这样一种假说,即患有多发性硬化症(MS)且携带载脂蛋白E(ApoE)ε4等位基因的患者,其病程可能比未携带ApoE ε4等位基因的患者更为严重。这似乎与ApoE ε4携带者更广泛的组织破坏以及更低效的神经元维持和修复有关。

目的

评估不同ApoE基因型对复发缓解型多发性硬化症(RRMS)患者脑组织完整性的影响。

设计

我们测定了76例RRMS患者的ApoE基因型。为每位患者以及一组人口统计学匹配的健康对照者获取了常规T1加权、T2加权和质子密度加权磁共振(MR)图像。在常规T1加权MR图像上,使用自动分析工具获取针对头部大小进行标准化的全脑体积(NBV)。在质子密度加权和T2加权MR图像上估计全脑病变负荷。

结果

在整个RRMS患者组中,我们鉴定出18例携带ε4等位基因的患者和58例未携带该等位基因的患者。两组患者在年龄、发病年龄、临床残疾程度和病程方面均无显著差异。携带ε4等位基因的患者的NBV显著低于对照组和未携带ε4等位基因的患者(P = 0.01)。当仅对那些病程极短且无临床残疾的患者进行类似分析时,携带ε4等位基因的RRMS患者的NBV值仍显著低于未携带该等位基因的患者(P = 0.02)以及对照组(P = 0.007)。相比之下,不同ApoE基因型的RRMS患者在全脑T2加权病变体积值方面未显示出显著差异。

结论

仅在携带ApoE ε4基因型的RRMS患者组中出现显著的NBV降低,这为MS中ApoE ε4相关的细胞修复受损机制和严重组织破坏之间的联系提供了新证据。本研究结果表明,ApoE ε4基因型的这种负面影响可能在疾病的最早阶段就已存在。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验